While promising results have been reported, there is still insufficient evidence to recommend laser therapy over other alternatives.1 Finally, atypical melanocytes that have lost their pigment-forming capacity may be resistant to laser therapy (Table 9)
Although it has not been compared directly, this weight loss is greater than with other treatments
Data from nationwide registers from Sweden, Denmark and Norway showed that patients initiating SGLT-2i were less likely to develop renal adverse events, such as RRT, hospitalization, or death for renal causes, compared to GLP-1RA users [37]
Kt qu cho thy thuc c th ci thin lu lng mu n tim v gim nguy c xy ra hin tng khng ti ti mu, y l tnh trng cc mao mch khng m li sau nhi mu, d can thip iu tr
Unlike Tirzepatide, it mimics only GLP-1 , the hormone responsible for stimulating insulin release, reducing glucagon, and slowing digestion (14)